State Street reports 5.1% stake in Sellas Life Sciences
State Street reported a 5.1% stake in Sellas Life Sciences. Victory Capital also disclosed a nearly 1,000% increase in its holdings; the supplied text does not specify the resulting stake.
Shares of Sellas Life Sciences Group (SLS) rose nearly 1% after hours on Tuesday as big-money disclosures drew attention, with State Street reporting a 5.1% stake and Victory Capital revealing a nearly 1,000% increase in holdings ahead of a key leukemia trial readout.SLS stock fell 2% on Tuesday to…